TheScreener
Fundamental and technical screening for 1,000 listed companies.
Use ⌘K to search stocks, screens, and features instantly.
Lenskart Solutions Ltd.
LENSKARTLarge CapNSEBSE
Medical Equipment & Supplies · Consumer Services
₹637.15down 3.45down 0.54 percentas of 28 Aug 2026
Book value ₹50.05
Key metrics
- Market Cap
- 1,08,733.43 ₹ cr
- P/E
- 220.86 x
- P/B
- 12.73 x
- ROE
- 12.78%
- ROCE
- 14.79%
- Debt to Equity
- 0.36 x
- Net Margin
- 8.36%
- Dividend Yield
- —
- Revenue Growth (YoY)
- 43.27%
Observations
Mechanical observations generated from stored data, not analysis or opinion. Each one names the threshold that produced it — the ROCE check below uses 20%, a fixed default rather than a value tailored to this company.
- ROCE below 20% in each of the last 3 financial years (2023-2024, 2024-2025, 2025-2026).
- Revenue grew year-on-year in each of the last 3 years.
- Net margin grew year-on-year in each of the last 3 years.
- Promoter holding 17.5% (pledge data not available).
- Debt-to-equity 0.36 — above the Consumer Services median of 0.36.
LENSKART
₹637.15down 0.54 percent
EOD Synced: 28 Aug 2026 18:30 ISTOverview & Live Price Chart
Executive Investment Verdict & Quality Synthesis
Autonomous V2Multi-dimensional quantitative synthesis across capital efficiency, forensic accounting, intrinsic valuation, and ownership governance.
Factual Quantitative Consensus
1. Capital Efficiency & MoatCapital Intensive
6.48%ROCE
ROE: 5.65%·P/B: 12.73x
2. Forensic Health & SolvencyPiotroski 8/9 · Strong Health
8/9Piotroski Score
Altman: 3.3 (Safe Zone)
3. Valuation & DCF Spread-88.9% Valuation Premium
₹71DCF Fair Value
CMP: ₹637.2
4. Ownership & GovernanceWidely Held / Low Promoter
17.53%Promoter Stake
Pledged: 0.0%·Inst: 24.96%
Institutional Factor Scores
QVGM Factor Grade Matrix
Institutional Multi-Factor Profile (QVGM)
Composite 0–100 percentile ranks normalized across all 500 universe constituents
Rank #1 of 1 in Medical Equipment & SuppliesQVGM 55/100
Quality (Q)54
ROE, ROCE, Margins & Cash Conversion
Value (V)16
P/E, P/B, EV/EBITDA vs Sector Benchmarks
Growth (G)68
3Y Sales & EPS Compounded Growth
Momentum (M)88
Relative Strength & Trend Position
TheScreener Radar™ 5-Pillar Quantitative Scorecard
Holistic quantitative radar evaluating fundamental quality, valuation multiples, balance sheet health, growth, and price momentum
Sector Rank:Rank #1 of 1 in Medical Equipment & Supplies
Valuation
Weak16/100
P/E Ratio:220.86x
P/B Ratio:12.73x
Dividend Yield:0.00%
P/E, P/B, EV/EBITDA & Dividend Yield relative to 5Y medians and sector
Growth
Moderate68/100
3Y Sales CAGR:—
3Y PAT CAGR:—
Quarterly YoY:+12.4%
3-Year Compounded Sales & Net Profit Growth trajectory
Profitability
Moderate54/100
ROE:5.6%
ROCE:6.5%
OPM %:—
Return on Equity (ROE), ROCE & Operating Margin efficiency
Solvency & Health
Strong89/100
Piotroski F-Score:8/9
Altman Z-Score:3.30
Debt / Equity:0.00
Balance Sheet strength, Altman Z-Score & Piotroski F-Score checklist
Momentum
Strong88/100
1Y Return:—
RSI (14):54.2
From 52W High:—
1-Year Relative Strength vs NIFTY 500, RSI-14 & 52W High distance
Quantitative Drivers & Growth Analysis
52-week corridor, deep valuation multiples, compounded CAGR trajectory, and institutional flow shifts
52-Week Low₹400.15
From 52W High-3.67%
52-Week High₹661.40
Valuation MultiplesCash Flow & Yield
PEG Ratio—
Earnings Yield27.09%
Price / FCF578.99
FCF Yield0.17%
Payout Ratio—
Net-Net Ratio-4.01
Solvency & SafetyPiotroski & Altman
Piotroski F-Score8/9
Altman Z-Score3.30
Graham Number₹440.84
1Y Flow & Margin ShiftsTrailing 12M
FII Stake:▲ +8.50%
DII Stake:▲ +5.77%
OPM Margin:▲ +3.35%
Net Margin:▲ +1.16%
Compounded Annual Growth Rate (CAGR Matrix)
Historical Fundamental Trajectory| Metric | QoQ Shift | YoY Shift | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Revenue Growth | ▲ +7.89% | ▲ +43.27% | 32.49% | 32.51% | 10.03% |
| Net Profit Growth | ▲ +10.76% | ▲ +262.66% | 66.99% | — | 10.03% |
| EPS Growth | ▲ +12.28% | ▲ +228.21% | 73.26% | — | 10.96% |
Intrinsic Valuation Models & DCF Sensitivity
Institutional DCF & Intrinsic Valuation Studio — LENSKART
2-Stage Discounted Cash Flow, Reverse DCF Implied Growth, and Benjamin Graham & Peter Lynch valuation benchmarks.
DCF Intrinsic Fair Value
₹72.7
Verdict:Overvalued (-88.6%)
Benjamin Graham Number
₹58.1
-90.9% vs CMPPeter Lynch Fair Value
₹59.9
-90.6% vs CMPReverse DCF Implied Growth
60.0% CAGR
Aggressive Expectations (Priced for Perfection)Valuation Spectrum PositioningCMP: ₹637.2
₹0 (Distress)CMP: ₹637DCF: ₹73Graham: ₹58
Scenario Calibration & Sensitivity Levers
Tune Discount Rate (WACC), 5-Year Growth, and Terminal Value to model bear, base, and bull cases.
Discount Rate (WACC)11.5%
Cost of Capital Hurdle
5-Year FCF Growth CAGR6.0%
Assumed stage-1 cash flow expansionTerminal Growth Rate4.5%
Long-term perpetual GDP growth rate5-Year Projected Cash Flow Schedule (₹ Cr)
| Projection Period | Growth Rate | Projected FCF | Discount Factor | Present Value |
|---|---|---|---|---|
| Year 1 | 6% | ₹996 | 0.8969 | ₹893 |
| Year 2 | 6% | ₹1,056 | 0.8044 | ₹849 |
| Year 3 | 6% | ₹1,119 | 0.7214 | ₹807 |
| Year 4 | 6% | ₹1,186 | 0.6470 | ₹767 |
| Year 5 | 6% | ₹1,257 | 0.5803 | ₹729 |
2D Sensitivity Matrix (WACC vs Terminal Growth Rate)
Click any cell to apply WACC & terminal growth scenario. Values in ₹ / share.| WACC \ g(Terminal) | 3.0% | 4.0% | 4.5% | 5.0% | 6.0% |
|---|---|---|---|---|---|
| 10.0% | ₹77 -88% | ₹89 -86% | ₹96 -85% | ₹105 -83% | ₹130 -80% |
| 11.0% | ₹66 -90% | ₹74 -88% | ₹79 -88% | ₹86 -87% | ₹101 -84% |
| 11.5% | ₹61 -90% | ₹68 -89% | ₹73 -89% | ₹78 -88% | ₹91 -86% |
| 12.0% | ₹57 -91% | ₹63 -90% | ₹67 -89% | ₹71 -89% | ₹82 -87% |
| 13.0% | ₹50 -92% | ₹55 -91% | ₹57 -91% | ₹61 -90% | ₹69 -89% |
Discounted cash flow (DCF) and valuation models are quantitative projections based on user-supplied assumptions — not a forecast, not a guarantee of future performance, and not SEBI-registered investment advice. Actual financial performance and stock price movements may differ materially.
New to intrinsic valuation models? Learn how Discounted Cash Flow and Terminal Growth rates work.Read DCF Academy Guide →
Valuation history
P/E220.86current
ReportedComputed, approximate
P/B12.73current
ReportedComputed, approximate
The dashed line is computed from historical close price divided by the most recently reported annual EPS or book value — not IndianAPI's own figure, which only ever gives a single current reading with no history behind it. Real results are typically disclosed several weeks after the fiscal year ends, so a computed point right around a year transition can lag what the market actually knew that day. The solid line is the real reported figure.
EV/EBITDA is not shown — there is no verified source for it in our data feed, and estimating it would misrepresent an estimate as a reported figure.
| Date | P/E | P/B |
|---|---|---|
| 31 Aug 2026 | 220.86 | 12.73 |
Analyst Consensus, Price Targets & Forecasts
Analyst Consensus & Recommendations
Aggregated institutional equity research ratings · 31 Aug 2026
Hold(2.67 / 5)
Strong Buy:0
Buy:0
Hold:0
Sell:0
Strong Sell:0
Ratings shown are third-party analyst estimates compiled from institutional brokers. They do not constitute investment advice.
Risk Profile & Volatility
Statistical return volatility classification · 31 Aug 2026
Balanced risk
Low RiskModerate RiskHigh Risk
Annualised Standard Deviation:27.92%
Analyst Price Targets
12-month forward price consensus · 31 Aug 2026
Upside: -32.83%
Mean Target₹428.00vs CMP ₹637.15
High Target₹500.00+-21.5% max upside
Low Target₹339.00-46.8% downside
Median Target₹445.003 estimates
Low: ₹339.00Mean: ₹428.00High: ₹500.00
Mean Target Current Price (₹637.15)
Price targets are third-party analyst estimates compiled from institutional brokers. They do not constitute investment advice.
Forward Financial Forecasts & Consensus Estimates
Institutional broker consensus estimates and forward earnings trajectory
FY2023EConsensus
Mean Estimate
—
Low:—
High:—
FY2023EConsensus
Mean Estimate
—
Low:—
High:—
FY2023EConsensus
Mean Estimate
—
Low:—
High:—
FY2023EConsensus
Mean Estimate
—
Low:—
High:—
FY2024EConsensus
Mean Estimate
—
Low:—
High:—
FY2024EConsensus
Mean Estimate
—
Low:—
High:—
FY2024EConsensus
Mean Estimate
—
Low:—
High:—
FY2024EConsensus
Mean Estimate
—
Low:—
High:—
FY2025EConsensus
Mean Estimate
—
Low:—
High:—
FY2025EConsensus
Mean Estimate
—
Low:—
High:—
FY2025EConsensus
Mean Estimate
—
Low:—
High:—
FY2025EConsensus
Mean Estimate
—
Low:—
High:—
FY2026EConsensus
Mean Estimate
—
Low:—
High:—
FY2026EConsensus
Mean Estimate
—
Low:—
High:—
FY2026E1 Analysts
Mean Estimate
₹0.53
Low:—
High:—
FY2026E1 Analysts
Mean Estimate
₹0.60
Low:—
High:—
FY2027E1 Analysts
Mean Estimate
₹0.69
Low:—
High:—
FY2027E1 Analysts
Mean Estimate
₹0.72
Low:—
High:—
FY2027E1 Analysts
Mean Estimate
₹0.74
Low:—
High:—
FY2027E1 Analysts
Mean Estimate
₹0.83
Low:—
High:—
| Period / Fiscal Year | Consensus Mean | Bull Case (High) | Bear Case (Low) | Brokers |
|---|---|---|---|---|
| FY2023 Forecast | — | — | — | — |
| FY2023 Forecast | — | — | — | — |
| FY2023 Forecast | — | — | — | — |
| FY2023 Forecast | — | — | — | — |
| FY2024 Forecast | — | — | — | — |
| FY2024 Forecast | — | — | — | — |
| FY2024 Forecast | — | — | — | — |
| FY2024 Forecast | — | — | — | — |
| FY2025 Forecast | — | — | — | — |
| FY2025 Forecast | — | — | — | — |
| FY2025 Forecast | — | — | — | — |
| FY2025 Forecast | — | — | — | — |
| FY2026 Forecast | — | — | — | — |
| FY2026 Forecast | — | — | — | — |
| FY2026 Forecast | ₹0.53 | — | — | 1 |
| FY2026 Forecast | ₹0.60 | — | — | 1 |
| FY2027 Forecast | ₹0.69 | — | — | 1 |
| FY2027 Forecast | ₹0.72 | — | — | 1 |
| FY2027 Forecast | ₹0.74 | — | — | 1 |
| FY2027 Forecast | ₹0.83 | — | — | 1 |
Third-party broker forecasts compiled from institutional research houses, not IndiScreener's proprietary estimates. Provided strictly for analytical benchmarking and does not constitute investment advice.
Forensic Accounting Audit & Solvency Risk
Accounting Health & Governance Quality Radar
Algorithmic accounting analysis across balance sheet solvency, cash conversion efficiency, and ownership stability.
Clean Governance & Solvency
Financial Strengths & Catalysts
3 Factors- •Company maintains conservative leverage with D/E of 0.35x.
- •Company has demonstrated healthy revenue growth of 32.5% CAGR over 3 years.
- •Strong cash generation: Operating Cash Flow is 358.1% of reported Net Profit.
Risk Factors & Watchouts
2 Watchouts- •Return on Equity (ROE) is currently modest at 5.6%.
- •Stock is trading at an elevated valuation multiple of 220.9x P/E.
Forensic Accounting & Health Audit
Piotroski F-Score, Altman Z-Score Distress Model & Beneish Earnings Manipulation Checks
Piotroski F-Score8 / 9
● Strong (High Quality)
Altman Z-Score3.30
● Safe Zone
Negligible risk of financial distress over the next 2 years.
Beneish M-Score-3.10
● Low Risk (Clean Accounting)
Cash flows closely match reported earnings with conservative accruals.
Learn how Piotroski F-Score (9 criteria) and Altman Z-Score detect earnings manipulation and bankruptcy risk.Read Forensic Guide →
10-Year Financial Statements & DuPont ROE
Financial Statements
consolidated · amounts in ₹ Crores
Accounting Flow:
Wall Street Cash Flow & Free Cash Flow (FCF) Cascade
FY26 (2025-2026)3-Stage institutional flow from reported earnings to owner Free Cash Flow and capital allocation
FCF Conversion Rate (FCF / PAT)
190.3%Elite Cash Quality (>100%)
Measures how much reported accounting profit turns into real liquid cash.
Free Cash Flow Margin
10.7%of Gross Revenue
Liquid cash retained per ₹100 of top-line revenue generated.
CapEx Reinvestment Rate
46.9%of Operating Cash
Portion of operating cash reinvested in future capacity and maintenance.
Reported Net Profit (PAT)₹494 CrInflow
494
+ D&A Non-Cash Charge₹1,048 CrAdd-back
1,048
Working Capital Adjustment₹226 Cr+ Cash
226
= Operating Cash Flow (CFO)₹1,768 CrOperating Cash
1,768
- Capital Expenditures (CapEx)-₹828 CrReinvestment
828
= Free Cash Flow (FCF)₹939 CrFree Cash Flow
939
- Dividends & Debt Repayment-₹109 CrCapital Return
109
= Net Change in Cash₹830 CrNet Balance
830
Multi-Year Historical FCF vs Reported PAT Trajectory:
Free Cash Flow (FCF) Reported Net Profit (PAT)
| Metric | 2018-201931 Mar 2019 | 2019-202031 Mar 2020 | 2020-202131 Mar 2021 | 2021-202231 Mar 2022 | 2022-202331 Mar 2023 | 2023-202431 Mar 2024 | 2024-202531 Mar 2025 | 2025-202631 Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹4,407.02 | ₹4,935.86 | ₹5,464.70 | ₹6,346.11 | ₹3,788.03 | ₹5,427.70 | ₹6,652.52 | ₹8,814.04 |
| Operating profit | ₹881.40 | ₹996.06 | ₹1,112.61 | ₹1,311.11 | ₹-156.79 | ₹27.02 | ₹359.56 | ₹771.29 |
| OPM | 20.00% | 20.18% | 20.36% | 20.66% | -4.14% | 0.50% | 5.40% | 8.75% |
| Net profit | ₹246.81 | ₹276.42 | ₹306.04 | ₹355.40 | ₹-63.76 | ₹-10.15 | ₹295.59 | ₹493.61 |
| EPS | 1.43 | 1.60 | 1.77 | 2.06 | -0.36 | -0.03 | 1.72 | 2.98 |
| Net margin | 5.60% | 5.60% | 5.60% | 5.60% | -1.68% | -0.19% | 4.44% | 5.60% |
| ROE | 9.26% | 9.26% | 9.26% | 9.26% | -1.16% | -0.18% | 4.85% | 5.65% |
| ROCE | 24.91% | 25.13% | 25.35% | 25.73% | -1.97% | 0.34% | 4.18% | 6.48% |
| Debt / equity | 0.33 | 0.33 | 0.33 | 0.33 | 0.43 | 0.39 | 0.42 | 0.35 |
Compounded growth (CAGR)
| Metric | 1Y | 3Y | 5Y |
|---|---|---|---|
| Revenue | 32.49% | 32.51% | 10.03% |
| Net profit | 66.99% | — | 10.03% |
| EPS | 73.26% | — | 10.96% |
Each column only appears when 8 real reported years actually support it — never extrapolated from fewer.
Balance sheet
| Metric | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₹4,847.72 | ₹5,429.45 | ₹6,011.18 | ₹6,980.72 | ₹9,528.28 | ₹9,531.02 | ₹10,471.02 | ₹14,413.32 |
| Total liabilities | ₹2,181.47 | ₹2,443.25 | ₹2,705.03 | ₹3,141.32 | ₹4,054.47 | ₹3,881.73 | ₹4,372.29 | ₹5,674.81 |
| Total equity | ₹2,666.25 | ₹2,986.20 | ₹3,306.15 | ₹3,839.40 | ₹5,473.81 | ₹5,649.29 | ₹6,098.73 | ₹8,738.51 |
| Total debt | ₹872.59 | ₹977.30 | ₹1,082.01 | ₹1,256.53 | ₹2,358.38 | ₹2,175.84 | ₹2,572.26 | ₹3,095.57 |
| Cash | ₹581.73 | ₹651.53 | ₹721.34 | ₹837.69 | — | ₹263.65 | ₹624.13 | ₹787.07 |
| Current assets | ₹2,181.47 | ₹2,443.25 | ₹2,705.03 | ₹3,141.32 | ₹3,913.35 | ₹3,437.30 | ₹3,630.03 | ₹5,670.43 |
| Current liabilities | ₹1,211.93 | ₹1,357.36 | ₹1,502.79 | ₹1,745.18 | ₹1,588.04 | ₹1,510.04 | ₹1,868.55 | ₹2,507.56 |
| Inventory | ₹440.70 | ₹493.59 | ₹546.47 | ₹634.61 | ₹611.19 | ₹728.12 | ₹1,145.21 | ₹1,183.86 |
| Receivables | ₹528.84 | ₹592.30 | ₹655.76 | ₹761.53 | ₹281.07 | ₹341.40 | ₹125.89 | ₹185.90 |
| Payables | ₹396.63 | ₹444.23 | ₹491.82 | ₹571.15 | ₹577.23 | ₹516.17 | ₹739.96 | ₹952.13 |
| Net PP&E | ₹1,939.09 | ₹2,171.78 | ₹2,404.47 | ₹2,792.29 | ₹1,685.92 | ₹1,830.53 | ₹3,555.87 | ₹4,673.91 |
| Retained earnings | ₹1,999.69 | ₹2,239.65 | ₹2,479.61 | ₹2,879.55 | — | ₹-1,278.61 | ₹-978.14 | ₹-513.43 |
Cash flow
| Metric | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | ₹308.51 | ₹345.53 | ₹382.55 | ₹444.25 | ₹94.74 | ₹487.38 | ₹1,230.63 | ₹1,767.85 |
| Capital expenditure | ₹264.42 | ₹296.15 | ₹327.88 | ₹380.77 | ₹-412.84 | ₹-437.70 | ₹-426.70 | ₹-828.47 |
| Free cash flow | ₹44.09 | ₹49.38 | ₹54.67 | ₹63.48 | ₹-318.10 | ₹49.68 | ₹803.93 | ₹939.38 |
| OCF / net profit | 1.25 | 1.25 | 1.25 | 1.25 | -1.49 | -48.02 | 4.16 | 3.58 |
| FCF / Capex intensity | 0.06 | 0.06 | 0.06 | 0.06 | 10.90 | 8.06 | 6.41 | 9.40 |
Income statement detail
| Metric | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|---|
| Gross profit | ₹1,542.46 | ₹1,727.55 | ₹1,912.65 | ₹2,221.14 | ₹2,399.05 | ₹3,628.96 | ₹4,488.54 | ₹6,037.65 |
| Cost of revenue | ₹2,864.56 | ₹3,208.31 | ₹3,552.06 | ₹4,124.97 | ₹1,388.98 | ₹1,798.74 | ₹2,163.98 | ₹2,776.39 |
| EBITDA | ₹969.54 | ₹1,085.89 | ₹1,202.24 | ₹1,396.14 | ₹190.67 | ₹579.32 | ₹1,026.87 | ₹1,819.67 |
| Income before tax | ₹328.25 | ₹367.64 | ₹407.03 | ₹472.68 | ₹-101.18 | ₹59.03 | ₹385.36 | ₹680.33 |
| Interest expense | ₹220.35 | ₹246.79 | ₹273.24 | ₹317.31 | — | — | — | ₹94.36 |
| Tax expense | ₹81.45 | ₹91.22 | ₹100.99 | ₹117.28 | ₹-37.42 | ₹69.19 | ₹88.02 | ₹179.38 |
| D&A | ₹176.28 | ₹197.43 | ₹218.59 | ₹253.84 | ₹347.46 | ₹552.30 | ₹667.31 | ₹1,048.38 |
| EBITDA margin | 22.00% | 22.00% | 22.00% | 22.00% | 5.03% | 10.67% | 15.44% | 20.65% |
Financial ratios
| Metric | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 | 2025-2026 |
|---|---|---|---|---|---|---|---|---|
| Current ratio | 1.80 | 1.80 | 1.80 | 1.80 | 2.46 | 2.28 | 1.94 | 2.26 |
| Quick ratio | 1.44 | 1.44 | 1.44 | 1.44 | 2.08 | 1.79 | 1.33 | 1.79 |
| Interest coverage | 4.00 | 4.04 | 4.07 | 4.13 | — | — | — | 8.17 |
| Inventory days | 45.00 | 45.00 | 45.00 | 45.00 | 160.61 | 147.75 | 193.16 | 155.64 |
| Receivable days | 35.00 | 35.00 | 35.00 | 35.00 | 27.08 | 22.96 | 6.91 | 7.70 |
| Payable days | 40.00 | 40.00 | 40.00 | 40.00 | 151.69 | 104.74 | 124.81 | 125.17 |
| Cash conversion cycle | 40.00 | 40.00 | 40.00 | 40.00 | 36.01 | 65.97 | 75.26 | 38.16 |
| Working capital days | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 |
| Fixed asset turnover | 2.27 | 2.27 | 2.27 | 2.27 | 2.25 | 2.97 | 1.87 | 1.89 |
| ROA | 5.09% | 5.09% | 5.09% | 5.09% | -0.67% | -0.11% | 2.82% | 3.42% |
| ROIC | 8.35% | 8.35% | 8.35% | 8.35% | — | -0.06% | 3.45% | 5.14% |
| Gross margin | 35.00% | 35.00% | 35.00% | 35.00% | 63.33% | 66.86% | 67.47% | 68.50% |
DuPont 3-Stage ROE Factor Decomposition
Deconstructing Return on Equity into Profitability, Asset Efficiency, and Financial Leverage
Balanced Return EngineFY2025-2026
Net marginProfitability
5.60%
Net Profit generated per ₹100 of revenue (Profitability)
×
Asset turnoverEfficiency
0.61
Revenue generated per ₹1 of total assets (Capital Efficiency)
×
Equity multiplierLeverage
1.65
Total assets supported per ₹1 of shareholder equity (Leverage)
=
Implied DuPont ROEFinal Output
5.65%
Reported: 5.65%
Explore the 3-Stage DuPont Formula: Net Margin × Asset Turnover × Leverage Multiplier.Read DuPont Guide →
Corporate Actions, Dividends & Capital Changes
Chronological Corporate Actions Registry
Historical stock splits, bonus shares, rights issues, and corporate schemes
No corporate actions or splits have been recorded for this company.
Industry Peer Group & Valuation Spread
Compare valuation multiples and market cap relative to sector competitors
Consumer ServicesCompare Peers in Studio
Market Cap1,08,733.43 ₹ cr
Beats 93% of 45 industry peers · median 10,623.18 ₹ cr
P/E220.86 x
Beats 93% of 30 industry peers · median 43.07 x
P/B12.73 x
Beats 88% of 40 industry peers · median 5.80 x
ROE12.78%
Beats 56% of 43 industry peers · median 10.06%
ROCE14.79%
Beats 58% of 43 industry peers · median 10.78%
Debt to Equity0.36 x
Beats 51% of 43 industry peers · median 0.36 x
Net Margin8.36%
Beats 49% of 43 industry peers · median 8.61%
Revenue Growth (YoY)43.27%
Beats 91% of 43 industry peers · median 16.47%
| Company | Market Cap ▼ | P/E | P/B |
|---|---|---|---|
Eternal Ltd.ETERNAL | ₹3.16 L | 831.85 | 9.73 |
| ₹2.49 L | 83.95 | 10.21 | |
Trent Ltd.TRENT | ₹1.53 L | 89.86 | 22.12 |
Indian Hotels Co. Ltd.INDHOTEL | ₹1.00 L | — | — |
Meesho Ltd.MEESHO | ₹96,215.69 | — | 21.61 |
Peers are chosen strictly by industry classification. A classification doesn't always describe what a company actually competes in, but gives an objective starting point across the universe.
Regulatory Filings & Market Intelligence
Corporate Filings & Document Vault
SEBI LODR VerifiedAudited Annual Reports, Investor Decks, Earnings Concall Transcripts, and Board Resolutions for Lenskart Solutions Ltd. (LENSKART)
Indexed Documents7 Filings
Latest Disclosure29 Jul 2026
Press Release29 Jul 2026
Lenskart Solutions Ltd.: Press Release: Business Updates and New Strategic Initiatives
AGM / EGM03 Jul 2026
Lenskart Solutions Ltd.: Notice of Annual General Meeting and Record Date for Dividend
Shareholding15 Jun 2026
Lenskart Solutions Ltd.: Quarterly Statement of Shareholding Pattern filed with NSE/BSE
Investor Deck10 Apr 2026
Lenskart Solutions Ltd.: Investor Presentation on Q4 Financial Results and Growth Outlook
Secretarial Filing13 Mar 2026
Lenskart Solutions Ltd.: Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015
Corporate Action27 Feb 2026
Lenskart Solutions Ltd.: Recommendation of Final Dividend for the Financial Year 2025-26
News
- IndianAPIGlobal PE firm Siguler Guff eyes $350-400 mn continuation fund to back four portfolio cos
Siguler Guff is considering the fund to stay invested in value-retail chain Baazar Kolkata, multi-specialty chain Sterling Hospitals, appliance maker Luker Electric Technologies and medical device maker Relisys
- IndianAPIStock market today: Gift Nifty hints a flat start; eight day trading stocks to buy on Wednesday, 19 August
Indian stock markets are anticipated to open flat amidst weak global cues, following a steep decline in the previous session. Brent crude prices rose amid supply concerns, while global financial markets remain risk-averse due to the US-Iran standoff and its impact on energy supplies.
- IndianAPIRaja Venkatraman recommends three stocks for 19 August
Market expert Raja Venkatraman shares his top stock picks for 19 August. Here’s his technical outlook and trade strategy.
- IndianAPISensex crashes almost 500 points, Nifty 50 extends losses for 6th consecutive session
The Sensex crashed 493 points, or 0.63%, to end at 77,235.46 on Tuesday, 18 August, while the NSE barometer Nifty 50 extended losses for the sixth consecutive session, ending with a loss of 133 points, or 0.55%, at 24,154.90.
- IndianAPITop Gainers & Losers on 18 August: PTC Industries, Inox Wind, Mphasis, Tata Elxsi, Suzlon Energy among top losers
Indian stock indices faced losses for the sixth session on August 18, closing 0.50% lower amid ongoing foreign selling and hesitant market sentiment influenced by renewed Middle East tensions.
- IndianAPILenskart shares gain over 5% to record high after incorporating new step-down subsidiary in China
Lenskart Solutions' shares rose 4% after incorporating Wenzhou Framekart Trade Co., Ltd. in China. The new subsidiary focuses on eyewear products, with BFT holding a 95% interest.
- IndianAPILenskart shares hit record high after Q1 profit jumps nearly four-fold; Motilal Oswal lifts target price
Lenskart Solutions' shares rose 7% to an all-time high of ₹627 after posting a net profit of ₹228 crore for Q1 FY27, a 273% increase. Revenue grew 43.3% YoY to ₹2,714.18 crore, driven by strong domestic and international demand for eyewear.
- IndianAPILenskart gets leg-up from international biz even as India expansion continues
Lenskart’s overseas business delivered a sharp margin boost in Q1, while India continued its store expansion. Sustaining profitability of new stores will be a key monitorable.
- IndianAPIStocks to watch: HAL, L&T, BEML among shares in focus today; check list here
Stock market today: Gift Nifty was trading near the 24,546.50 mark, up over 6 points from the previous close of Nifty futures.
- IndianAPITop Gainers & Losers on 10 August: Hitachi Energy, Paytm, Titian, BSE, BEML, Lenskart among top gainers
On August 10, the Indian stock market traded within a narrow range amid Middle East tensions affecting oil prices. Nifty 50 saw a slight increase of 0.05%, while Sensex dipped 0.06%. Sector performance varied, with heavy selling in some indices and gains in Realty and Private Bank stocks.
- IndianAPIStock market today: Gift Nifty hints a flat start; eight day trading stocks to buy on Tuesday, 28 July
Indian stock market indices, Sensex and Nifty 50, are expected to open flat due to weak global cues. Despite a five-day losing streak that ended yesterday, local markets posted gains. Oil prices dipped amid ongoing US-Iran diplomatic talks, impacting overall market sentiment.
- IndianAPIMSCI India August Review: Groww, Adani Green, Adani Energy among likely additions; Astral, SBI Cards face exclusion risk
MSCI India Standard Index rebalancing is scheduled to be announced on August 12 after market hours, which could see as many as 12 inclusions and three exclusions. This is estimated to lead to potential passive inflows of around $2.3 billion. The changes will take effect from August 31.
- IndianAPIManufacturing companies eclipse consumer firms in a cooling IPO market
Companies raised a record ₹1.96 trillion through 91 mainboard initial public offerings (IPOs) in 2024, followed by another ₹1.76 trillion across a record 103 issues in 2025. But activity cooled in 2026 amid volatile markets and geopolitical uncertainty, with 23 IPOs raising ₹21,506 crore so far.
- IndianAPIAfter SoftBank, ADIA plans over $200 million Lenskart sell-down
Platinum Jasmine A 2018 Trust, an investment vehicle of the Abu Dhabi Investment Authority, is offering up to 40 million shares, representing approximately 2.3% of Lenskart's outstanding equity.
- IndianAPIBlock Deals: Lenskart Solutions, GMR Airports shares to be in focus
Block Deals: SVF II Lightbulb (Cayman), an investment vehicle owned by SoftBank Group, sold 5.65 crore Lenskart shares, representing a 3.25% stake in the company at ₹508.55 apiece, taking the total deal value to ₹2,873.30 crore.
- IndianAPIStocks to watch: BHEL, NBCC, Lenskart, GMR Airports among 10 shares in focus today; check list here
Stock market today: The market is likely to continue its losing streak as trends in the Gift Nifty index signalled a negative opening on Thursday. Amid this backdrop, these stocks will remain in focus on 4 June.
For informational and educational purposes only. Not investment advice. Data may be delayed or incomplete. Consult a SEBI-registered investment adviser before making investment decisions.